Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight [Phase 2]

View source ↗

Summary

Eli Lilly is conducting a Phase 2 master protocol study (LY900038) with multiple intervention-specific appendices in adults with obesity or overweight. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY900038 (LY900038)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 2 | Status: RECRUITING